Group 1 - The claim that drinking hard water leads to kidney stones is a misconception; hard water is defined by its high mineral content, particularly calcium and magnesium, and does not directly cause kidney stones in healthy individuals [2][4] - Drinking insufficient water can concentrate urine, increasing the risk of urinary system stones, rather than the hardness of the water itself [4] Group 2 - Frequent hair washing does not cause hair loss; the shedding observed during washing is a natural process, as hair naturally falls out during its resting phase [5][7] - The primary factors influencing hair loss are related to immune response, genetics, hormone levels, stress, nutrition, and certain medications, rather than washing frequency [7] Group 3 - The belief that wounds must be disinfected with alcohol is a misconception; while alcohol is a common disinfectant, iodine-based solutions are often recommended for wound care due to their effectiveness and lower skin irritation [8][10] - Alcohol can damage healthy tissue around wounds, potentially hindering healing and leading to scarring [10] Group 4 - The notion that antihistamines can lead to dependency is incorrect; these medications are safe and effective without causing physical or psychological dependence [11][13] - Antihistamines work by blocking histamine receptors to alleviate allergy symptoms, and stopping their use does not result in withdrawal symptoms [13]

Core Viewpoint - The article highlights the urgent demand for effective allergy treatments in China, driven by a significant increase in allergy cases and the corresponding rise in medication sales, indicating a burgeoning market opportunity for pharmaceutical companies [3][8][9]. Market Dynamics - The pollen concentration in Beijing has surged, leading to a 40% year-on-year increase in allergy medication purchases, with specific orders for nasal allergy medications rising by 160% [8]. - The allergy medication market in China, currently valued at a low penetration compared to global standards, is projected to exceed $20 billion by 2030 due to increasing patient awareness and payment capabilities [8][9]. Product Trends - Traditional allergy medications like Loratadine have seen a significant sales increase, with total retail sales surpassing 7.6 billion yuan in the past five years, maintaining an annual growth rate of over 10% [11][13]. - New formulations and delivery methods, such as oral liquids and syrups, are being explored by pharmaceutical companies to enhance market competitiveness [11]. Innovation in Allergy Treatments - The introduction of innovative biologics, such as Dupilumab, which targets IL-4Rα, marks a significant advancement in allergy treatment, showing promising clinical results in alleviating symptoms [17]. - The global clinical trial landscape for allergy treatments has expanded, with over 1,600 studies registered, indicating a strong focus on developing new therapies [14]. Pricing and Market Challenges - Biologics, while effective, come with high price points, which may deter patients who prefer cost-effective options. Balancing efficacy and affordability remains a challenge for companies in this sector [19][20]. - Desensitization therapy, although lengthy, is viewed as a potential long-term solution for allergy sufferers, with companies like Iwubio reporting significant sales growth in their desensitization products [21]. Future Outlook - The allergy medication market is poised for growth, with numerous companies entering the space, seeking to capitalize on the increasing demand for effective treatments [21].